Recursion Pharmaceuticals uses artificial intelligence (AI) in its proprietary operating system to match new compounds ...

GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.

Shares of biotechnology stocks such as Recursion Pharmaceuticals (NASDAQ: RXRX), Summit Therapeutics (NASDAQ: SMMT), and CRISPR Therapeutics AG (NASDAQ: CRSP) plunged on Monday, down 9.4% ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Recursion Pharmaceuticals uses artificial intelligence ... as well as some cancers. Summit Therapeutics is much larger than the other two stocks, thanks to last year's promising Phase III results ...

The pharma industry, Wall Street and former government officials on Monday decried the forced resignation of FDA vaccine ...

Piramal believes that while passing the baton of the group's business, it is crucial for leaders—especially those accustomed ...

the new head of US human pharma at Boehringer Ingelheim. The IMPACCT Real World Evidence Summit is back, offering the opportunity to bring together 50+ pharma RWE decision makers to discuss ...

This discussion has become a moot point across sectors in India Inc., as promoters are looking at the next generation to not ...

Dr S Jaishankar, External Affairs Minister of India called on President Boric. President Boric and Prime Minister Modi ...

The IMPACCT Real World Evidence Summit is back, offering the opportunity to bring together 50+ pharma RWE decision makers to discuss integrated evidence plans, data sharing optimization ...